Purchase Order 75N95019P00455
Award Date 7/22/19
Potential Completion Date 7/30/19
Potential Value $11K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lafayette, CO 80026, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institutes of Health (NIH) to Dharmacon, Inc., a foreign-owned, for-profit company, to provide RNA interference (RNAi) reagents and related products to support research programs. The $24,999.00 purchase order contract does not have a set-aside designation. Dharmacon, a subsidiary of Thermo Electron Corporation, has received multiple prior awards from the NIH to supply custom RNAi libraries, CRISPR tools, and other genomic screening...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Dharmacon, Inc. for the provision of an siRNA (small interfering RNA) generation kit to simultaneously target four proteins for a publication. The contract has a total ceiling value of $3,178.76 and a completion date of November 20, 2011. Dharmacon, Inc. is a foreign-owned, for-profit organization that provides scientific research products and services to government agencies,...
- Dharmacon, Inc., a foreign-owned for-profit organization, received a $16,148.76 firm-fixed-price purchase order contract from the Department of Health and Human Services' National Institutes of Health, National Center for Advancing Translational Sciences. The contract is for the delivery of a Mimic library, which includes custom RNA interference reagents, genome libraries, and other products to support the agency's scientific research programs. This contract is not set aside for any specific...
- This is a federal contract award from the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) to Dharmacon, Inc., a foreign-owned for-profit company, for the provision of CRISPR-Cas9 single guide RNA (sgRNA) expression constructs and protein kinases. The $18,447.84 firm-fixed-price purchase order contract has a performance period ending on March 17, 2020. Dharmacon has received multiple previous awards from NCATS and the National Institute on Drug Abuse...
- This federal contract award was issued by the National Cancer Institute, a component of the National Institutes of Health within the U.S. Department of Health and Human Services. The award, valued at $21,438.00, was made to Dharmacon, Inc., a foreign-owned for-profit organization, to provide Dharmacon products and services. The contract was a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The award did not have a set-aside designation. Dharmacon, a subsidiary of...
- The National Institute of Child Health and Human Development awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Dharmacon, Inc., a foreign-owned scientific research supplier, for various On-TargetPlus siRNA SmartPool and On-TargetPlus non-targeting pool products. The contract, valued at $6,337.12, was awarded on July 21, 2016, with an ultimate completion date of July 20, 2017, and was performed in Bethesda, Maryland. No small business set-aside was utilized for this award....
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Dharmacon, Inc., a foreign-owned for-profit company, for the delivery of DHARMACON OTP MOUSE DRUGGABLE SET OF 4, 0.1 NM. The contract was set aside for small businesses, with a ceiling value of $92,029.00 and a completion date of August 10, 2020. The contract originated from a solicitation for custom RNA interference...
- On May 16, 2011, the National Institute on Aging awarded a Blanket Purchase Agreement (BPA) call contract valued at $9,504 to Dharmacon, Inc., a subsidiary of Thermo Electron Corporation. The contract, which carries no set-aside designation, is classified as Firm Fixed Price and was executed under Treasury Account Symbol 75-0843. Dharmacon, a foreign-owned, for-profit entity specializing in scientific research products and services, performed the work at its Lafayette, Colorado facility...
- This federal contract was awarded by the National Institutes of Health (NIH) to Dharmacon, Inc., a foreign-owned, for-profit company that provides scientific research products and services. The contract, valued at $29,850.00, is for the provision of a MOUSE MIRIDIAN MIRNA INHIBITOR LIBRARY (16.0) to support research programs across the NIH's National Center for Advancing Translational Sciences and National Institute on Drug Abuse. The contract was awarded as a Firm Fixed Price Blanket Purchase...
- This is a firm-fixed price purchase order valued at $23,517.00 awarded by the National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services, to Dharmacon, Inc., a foreign-owned for-profit organization, for the provision of ZOONOME CHO SIRNA LIBRARY. The award is designated as a Total Small Business set-aside. Dharmacon has received multiple federal contract awards from the agency, including for the supply of custom RNA interference...
Dharmacon, Inc., a foreign-owned for-profit corporation, was awarded a $11,316 fixed-price purchase order contract by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences. The contract is for the provision of custom RNA interference (RNAi) small interfering RNA (siRNA) plates to support scientific research programs. No set-aside designation was used. Dharmacon is a supplier of various scientific research products and services, including CRISPR libraries, gene editing tools, and drug target screening sets, to government agencies. The company has received multiple prior awards from NIH, some of which were designated as small business set-asides.
Generated 5/7/24, 12:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 7/22/19 |